Here, we demonstrate that the S351-phosphorylated p62 causes rearrangement of glucose and glutamine metabolism through persistent activation of Nrf2, which provides HCC cells with both tolerance to anti-cancer drugs and proliferation potency. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.